Season’s greetings with a new funding round for all!
From all of us at BIOPIX-T, we very much hope you have a Happy, Healthy and Successful New Year 2023!!!
We are about to launch a public bridge financing round in the coming weeks, followed by a full Series A round within the next two years. This bridge round will be funded by a combination of institutional investors who have already committed the majority of the necessary funds and a public crowdfunding campaign. All information about the terms and our future plans can be found by following this link: https://investors.seedblink.com/landing/2817c463e2c5f9c6 .
BIOPIX-T to participate in a H2020-RIA project granted for the early detection of Sepsis at the point-of-care!
We are pleased to announce that BIOPIX-T is participating as a design and commercialization partner, in a grant that was awarded to a consortium of 12 esteemed research institutions and companies, with the aim to develop a point-of-care device for the early detection of Sepsis.
BIOPIX-T voted by judges as top presenter in Tech Tour South East Europe 2021-2022
We are super-excited to announce that we have been selected as a winner of the 2021-2022 Tech Tour South East Europe Program after 2 rounds of intensive and competitive pitching sessions in Athens in May and online in June!
PEBBLE achieves IVDR declaration
Another important milestone achieved! Our declaration of conformity as per IVDR, for the PEBBLE qcLAMP Platform, was today approved by the Greek Organization for Medicines! We are one of the first companies in Greece to achieve the IVDR compliance for one of its products! Congratulations to all the BIOPIXers whose hard work and dedication led to this achievement!!!